RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. 35Pharma

35Pharma

35Pharma is a clinical-stage biopharmaceutical company focused on designing and developing TGF-beta superfamily therapeutics.

Latest funding

Series B+ ·

Amount not disclosed in a source on record.

Funding history ↓

Acquired by GGlaxoSmithKline on · The Globe and Mail.

Website: 35pharma.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biopharma, Biotechnology, Pharmaceutical.
Stage: Series B+.
Based in: Montreal, Canada.
Last round: Nov 26, 2024 · 720 days ago.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredJan 26, 2022 (4 years old)

Funding rounds

DateRoundAmountLeadSource
Series B+undisclosedFFrazier Life Sciencesfundraisingfox.com

Timeline

  1. Acquired by GGlaxoSmithKline
  2. Website created

Team

Investors

Companies like 35Pharma

Other companies backed by Frazier Life Sciences

Frazier Life Sciences portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/35pharma (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy